Medical Xpress3h
Treatment target for aggressive leukemia discovered by disrupting its genome organization
Although they do aid in directing the complex to the chromatin, they are not required for NURF to bind to its specific sites ...
News2423h
How tissue donations in KZN are helping to boost our understanding of TB
At Durban's King Dinuzulu Hospital, a TB patient with advanced lung disease awaits surgery for massive haemoptysis - severe ...
News Medical on MSN4h
Key reason why some cancers do not respond to immunotherapy identified
Research reveals SLC13A3's role in tumor cell survival and immune therapy resistance, highlighting its potential as a target ...
How immune cells 'sniff out' pathogens: Signaling study could speed up the search for new drugs
Immune cells are capable of detecting infections just like a sniffer dog, using special sensors known as Toll-like receptors, ...
High-resolution IR spectroscopy reveals new insights into the hydrogen bonding of hydrogen sulfide
Water and the bad smelling molecule hydrogen sulfide do not seem to have a lot in common at first sight. However, when ...
BioPharma Dive3h
Biotech investors, including Third Rock, pump $100M into a startup’s genetic medicine for ALS
Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...
Tau transforms from ‘good guy’ to a ‘bad guy,’ contributes to Alzheimer’s disease
Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas ...
Finanznachrichten12h
Belite Bio, Inc: Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Vitamin A is critical to normal vision but can accumulate as toxic byproducts in individuals affected with STGD1 and GA (the advanced form of dry age-related macular degeneration (dry AMD) leading to ...